Co-Author
This page shows the publications co-authored by Christine Lian and Nicole Leboeuf.
Connection Strength
1.969
-
Disseminated varicella-zoster virus infections following messenger RNA-based COVID-19 vaccination. JAAD Case Rep. 2021 Nov; 17:126-129.
Score: 0.240
-
Recalcitrant extramammary Paget's disease treated successfully with high-dose-rate brachytherapy: A case series and review of the literature. Dermatol Ther. 2021 03; 34(2):e14755.
Score: 0.229
-
De novo cutaneous connective tissue disease temporally associated with immune checkpoint inhibitor therapy: A retrospective analysis. J Am Acad Dermatol. 2021 Mar; 84(3):864-869.
Score: 0.225
-
De novo subacute cutaneous lupus erythematosus-like eruptions in the setting of programmed death-1 or programmed death ligand-1 inhibitor therapy: clinicopathological correlation. Clin Exp Dermatol. 2021 Mar; 46(2):328-337.
Score: 0.225
-
Reply to: "Comment on 'Bullous pemphigoid after anti-PD-1 therapy: A retrospective case-control study evaluating impact on tumor response and survival outcomes'". J Am Acad Dermatol. 2020 May 15.
Score: 0.218
-
Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression. JAAD Case Rep. 2020 Aug; 6(8):693-696.
Score: 0.218
-
Bullous pemphigoid after anti-PD-1 therapy: a retrospective case-control study evaluating impact on tumor response and survival outcomes. J Am Acad Dermatol. 2020 Jan 10.
Score: 0.213
-
Nonbullous pemphigoid secondary to PD-1 inhibition. JAAD Case Rep. 2019 Oct; 5(10):898-903.
Score: 0.209
-
Pityriasis rubra pilaris-like erythroderma secondary to phosphoinositide 3-kinase inhibition. Clin Exp Dermatol. 2018 Dec; 43(8):890-894.
Score: 0.191
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.